Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema

被引：47
作者：
Russo, Andrea [1 ]
Costagliola, Ciro [2 ]
Delcassi, Luisa [1 ]
Parmeggiani, Francesco [3 ]
Romano, Mario R. [4 ]
dell'Omo, Roberto [2 ]
Semeraro, Francesco [1 ]
机构：
[1] Univ Brescia, Dept Neurol & Vis Sci, Eye Clin, I-25123 Brescia, Italy
[2] Univ Molise, Dept Hlth Sci, Eye Clin, I-86100 Campobasso, Italy
[3] Univ Ferrara, Dept Ophthalmol, I-44121 Ferrara, Italy
[4] Ist Clin Humanitas, Eye Clin, I-20089 Milan, Italy
来源：
MEDIATORS OF INFLAMMATION | 2013年 / 2013卷
关键词：
KETOROLAC TROMETHAMINE 0.5-PERCENT; ENDOTHELIAL GROWTH-FACTOR; SELECTIVE CYCLOOXYGENASE-2 INHIBITOR; RANDOMIZED CONTROLLED-TRIAL; INDUCED OCULAR INFLAMMATION; EARLY DIABETIC-RETINOPATHY; FACTOR-H POLYMORPHISM; OPHTHALMIC SOLUTION; CATARACT-SURGERY; CHOROIDAL NEOVASCULARIZATION;
D O I：
10.1155/2013/476525
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Nonsteroidal anti-inflammatory drugs (NSAIDs) are nowadays widely used in ophthalmology to reduce eye inflammation, pain, and cystoid macular edema associated with cataract surgery. Recently, new topical NSAIDs have been approved for topical ophthalmic use, allowing for greater drug penetration into the vitreous. Hence, new therapeutic effects can be achieved, such as reduction of exudation secondary to age-related macular degeneration or diabetic maculopathy. We provide an updated review on the clinical use of NSAIDs for retinal diseases, with a focus on the potential future applications.
引用
收藏
页数：11
相关论文
共 128 条
[1]   Immunological mechanisms in the pathogenesis of diahetic retinopathy [J].
Adamis, Anthony P. ;
Berman, Adrienne J. .
SEMINARS IN IMMUNOPATHOLOGY, 2008, 30 (02) :65-84
[2]   Intravitreal injection of ketorolac tromethamine in patients with diabetic macular edema refractory to retinal photocoagulation [J].
Afonso Reis, Andreia do Ceu ;
Galvarro Vianna, Raul Nunes ;
Mendes dos Reis, Ricardo Siqueira ;
Cardoso, Gilberto Perez .
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2010, 73 (04) :338-342
[3]   Topical ocular delivery of NSAIDs [J].
Ahuja, Munish ;
Dhake, Avinash S. ;
Sharma, Surendra K. ;
Majumdar, Dipak K. .
AAPS JOURNAL, 2008, 10 (02) :229-241
[4]   SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS [J].
AIELLO, LP ;
PIERCE, EA ;
FOLEY, ED ;
TAKAGI, H ;
CHEN, H ;
RIDDLE, L ;
FERRARA, N ;
KING, GL ;
SMITH, LEH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10457-10461
[5]   Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification [J].
Almeida, David R. P. ;
Khan, Zainab ;
Xing, Lin ;
Bakar, Shahrukh N. ;
Rahim, Karim ;
Urton, Todd ;
El-Defrawy, Sherif R. .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2012, 38 (09) :1537-1543
[6]  
[Anonymous], 1991, Ophthalmology, V98, P757
[7]   Mechanisms of Disease Diabetic Retinopathy [J].
Antonetti, David A. ;
Klein, Ronald ;
Gardner, Thomas W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (13) :1227-1239
[8]   Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model [J].
Ayalasomayajula, SP ;
Kompella, UB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 458 (03) :283-289
[9]  
BAUDOIN C, 1989, DIABETES, V38, P491
[10]   FLURBIPROFEN 0.03-PERCENT FOR THE CONTROL OF INFLAMMATION FOLLOWING CATARACT-EXTRACTION BY PHACOEMULSIFICATION [J].
BLAYDES, JE ;
KELLEY, EP ;
WALT, JG ;
DEGRYSE, RE ;
HARPER, DG ;
NOVACK, GD .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 1993, 19 (04) :481-487
12345678910